Lowenstein Sandler

New Jersey

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases124

Challenger50%

Patent Owner50%

NPE50%

lowenstein-sandler

lowenstein.com

Practice Areas

BiotechChemical BiotechComp. Arch. and Software

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
09/13/24	Curia IP Holdings LLC v. Salix Pharmaceuticals Ltd 2:21-CV-19293 ( D. NJ )	Letter from E. Abraham to Judge Almonte re 249 Text Order,,,. (ABRAHAM, ERIC) (Entered: 09/13/2024)
11/09/23	Purdue Pharma LP v. Elite Laboratories Inc 1:23-CV-22221 ( D. NJ )	Corporate Disclosure Statement by PURDUE PHARMA L.P., PURDUE PHARMACEUTICALS L.P., RHODES TECHNOLOGIES. (FANG, WAYNE) (Entered: 11/09/2023)
11/13/23	Purdue Pharma LP v. Elite Laboratories Inc 1:23-CV-22221 ( D. NJ )	Magistrate Judge Ann Marie Donio added. (dmw) (Entered: 11/13/2023)
11/09/23	Purdue Pharma LP v. Elite Laboratories Inc 1:23-CV-22221 ( D. NJ )	COMPLAINT against ELITE LABORATORIES, INC., ELITE PHARMACEUTICALS, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14862247), filed by PURDUE PHARMA L.P., RHODES TECHNOLOGIES, PURDUE PHARMACEUTICALS L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Form AO 120 (Report on the Filing or Determination of an Action Regarding a Patent or Trademark), # 17 Civil Cover Sheet)(FANG, WAYNE) (Entered: 11/09/2023) COMPLAINT against ELITE LABORATORIES, INC., ELITE PHARMACEUTICALS, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14862247), filed by PURDUE PHARMA L.P., RHODES TECHNOLOGIES, PURDUE PHARMACEUTICALS L.P.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Form AO 120 (Report on the Filing or Determination of an Action Regarding a Patent or Trademark), # 17 Civil Cover Sheet)(FANG, WAYNE) (Entered: 11/09/2023)
08/02/23	Genentech Inc v. Sandoz Inc 2:23-CV-04085 ( D. NJ )	SUMMONS ISSUED as to LEK PHARMACEUTICALS D.D., SANDOZ, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (lag, ) (Entered: 08/02/2023)
08/02/23	Genentech Inc v. Sandoz Inc 2:23-CV-04085 ( D. NJ )	AO120 Patent Form filed. (Attachments: # 1 Complaint) (lag, ) (Entered: 08/02/2023)
08/02/23	Genentech Inc v. Sandoz Inc 2:23-CV-04085 ( D. NJ )	Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (kd) (Entered: 08/02/2023)
07/31/23	Genentech Inc v. Sandoz Inc 3:23-CV-04085 ( D. NJ )	NOTICE of Appearance by WAYNE W. FANG on behalf of GENENTECH, INC., HOFFMANN-LA ROCHE INC. (FANG, WAYNE) (Entered: 07/31/2023)
07/31/23	Genentech Inc v. Sandoz Inc 3:23-CV-04085 ( D. NJ )	Corporate Disclosure Statement by HOFFMANN-LA ROCHE INC. identifying Roche Holding Ltd. as Corporate Parent.. (OLIVER, MATTHEW) (Entered: 07/31/2023)
07/31/23	Genentech Inc v. Sandoz Inc 3:23-CV-04085 ( D. NJ )	Corporate Disclosure Statement by GENENTECH, INC. identifying Roche Holding Ltd. as Corporate Parent.. (OLIVER, MATTHEW) (Entered: 07/31/2023)